Literature DB >> 30595144

Vulvovaginal candidiasis: histologic lesions are primarily polymicrobial and invasive and do not contain biofilms.

Alexander Swidsinski1, Alexander Guschin2, Qionglan Tang3, Yvonne Dörffel4, Hans Verstraelen5, Alexander Tertychnyy6, Guzel Khayrullina2, Xin Luo7, Jack D Sobel8, Xuefeng Jiang7.   

Abstract

BACKGROUND: The recent demonstration of a vaginal biofilm in bacterial vaginosis and its postulated importance in the pathogenesis of recurrent bacterial vaginosis, including relative resistance to therapy, has led to the hypothesis that biofilms are crucial for the development of vulvovaginal candidiasis. The histopathology and microbial architecture of vulvovaginal candidiasis have not been previously defined; neither has Candida, containing biofilm been reported in situ. The present study aimed at clarifying the histopathology of vulvovaginal candidiasis including the presence or absence of vaginal biofilm. STUDY
DESIGN: In a cross-sectional study, vaginal tissue biopsies were obtained from 35 women with clinically, microscopically, and culture-proven vulvovaginal candidiasis and compared with specimens obtained from 25 healthy women and 30 women with active bacterial vaginosis. Vaginal Candida infection was visualized using fluorescent in situ hybridization with ribosomal gene-based probes.
RESULTS: Candida microorganisms were confirmed in 26 of 35 biopsies obtained from women with vulvovaginal candidiasis; however, Candida containing biofilm were not detected in any of the cases. Histopathological lesions were exclusively invasive and accompanied by co-invasion with Gardnerella or Lactobacillus species organisms.
CONCLUSION: Histopathological lesions of vulvovaginal candidiasis are primarily invasive in nature and polymicrobial and do not resemble biofilms. The clinical significance of Candida tissue invasion is unknown.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atopobium; Candida; Gardnerella; Lactobacillus crispatus and iners; biofilm; polymicrobial invasion; vulvovaginal candidiasis

Mesh:

Substances:

Year:  2018        PMID: 30595144     DOI: 10.1016/j.ajog.2018.10.023

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  23 in total

Review 1.  Vulvovaginitis Caused by Candida Species Following Antibiotic Exposure.

Authors:  Asmita Shukla; J D Sobel
Journal:  Curr Infect Dis Rep       Date:  2019-11-09       Impact factor: 3.725

2.  Current and promising pharmacotherapeutic options for candidiasis.

Authors:  Liliana Scorzoni; Beth Burgwyn Fuchs; Juliana Campos Junqueira; Eleftherios Mylonakis
Journal:  Expert Opin Pharmacother       Date:  2021-02-04       Impact factor: 3.889

Review 3.  Candida albicans biofilms and polymicrobial interactions.

Authors:  Nicole O Ponde; Léa Lortal; Gordon Ramage; Julian R Naglik; Jonathan P Richardson
Journal:  Crit Rev Microbiol       Date:  2021-01-22       Impact factor: 7.624

4.  Biofilm Formation of Candida albicans Facilitates Fungal Infiltration and Persister Cell Formation in Vaginal Candidiasis.

Authors:  Xueqing Wu; Sisi Zhang; Haiying Li; Laien Shen; Chenle Dong; Yao Sun; Huale Chen; Boyun Xu; Wenyi Zhuang; Margaret Deighton; Yue Qu
Journal:  Front Microbiol       Date:  2020-06-05       Impact factor: 5.640

5.  Anti-biofilm activity of chlorhexidine digluconate against Candida albicans vaginal isolates.

Authors:  Cathrin Alvendal; Soumitra Mohanty; Nina Bohm-Starke; Annelie Brauner
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

6.  Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment.

Authors:  Kathryn W Woodburn; L Edward Clemens; Jesse Jaynes; Lydia-Marie Joubert; Alfred Botha; Hasan Nazik; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

Review 7.  Vulvovaginal Candidiasis: A Current Understanding and Burning Questions.

Authors:  Hubertine M E Willems; Salman S Ahmed; Junyan Liu; Zhenbo Xu; Brian M Peters
Journal:  J Fungi (Basel)       Date:  2020-02-25

Review 8.  Applying the Host-Microbe Damage Response Framework to Candida Pathogenesis: Current and Prospective Strategies to Reduce Damage.

Authors:  Paul L Fidel; Junko Yano; Shannon K Esher; Mairi C Noverr
Journal:  J Fungi (Basel)       Date:  2020-03-11

Review 9.  Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: a critical review.

Authors:  Namarta Kalia; Jatinder Singh; Manpreet Kaur
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-01-28       Impact factor: 3.944

10.  RAFT-Derived Polymethacrylates as a Superior Treatment for Recurrent Vulvovaginal Candidiasis by Targeting Biotic Biofilms and Persister Cells.

Authors:  Xueqing Wu; Sisi Zhang; Xinxin Xu; Laien Shen; Boyun Xu; Wenzhen Qu; Wenyi Zhuang; Katherine Locock; Margaret Deighton; Yue Qu
Journal:  Front Microbiol       Date:  2019-11-07       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.